CLINICAL_TRIALS
trial_result
· 2012-02-28
Clinical Trial Update: Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB [Phase 3]
Summary
Phase 3 trial comparing telbivudine and tenofovir disoproxil fumarate in chronic hepatitis B evaluates HBV DNA kinetics; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Hepatitis B Virus | Phase 3 | Status: COMPLETED | Results posted: 2012-02-28